Lose 14-15% of your body weight* *In clinical trials of Wegovy (FDA-approved semaglutide), participants achieved an average weight loss of approximately 15% over 68 weeks, with some participants achieving up to 20% with continued treatment and adherence, when combined with diet and exercise
Zhu B, Gong N, Fan H, Peng CS, Ding XJ, Jiang Y, Wang YX (2014) Lamiophlomis Rotata, an orally available tibetan herbal painkiller, specifically reduces pain hypersensitivity states through the activation of spinal glucagon-like peptide-1 receptors
When administered under medical supervision, GLP-1 injections are FDA-approved, effective, and tailored to your specific health needs
Where Standard Dosing Begins In large randomized clinical trials, GLP-1 therapy begins at defined initiation thresholds before gradual titration upward
Like all GLP-1 medications, GLP-1 works best over time and alongside healthy habits